miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Research

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-12-4318PMID 23636127PMCID PMC3780786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of miR-124 inhibits growth of medulloblastoma cells.

  2013cited by this paper
• Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.

  2012cited by this paper
• Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells*

  2012cited by this paper
• microRNA‐124 Regulates Cardiomyocyte Differentiation of Bone Marrow‐Derived Mesenchymal Stem Cells Via Targeting STAT3 Signaling

  2012cited by this paper
• MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathway

  2011cited by this paper
• Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA*

  2011cited by this paper
• An HNF4a-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis

  2011cited by this paper
• Plasma miR-124 as a biomarker for cerebral infarction.

  2011cited by this paper
• Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

  2011cited by this paper
• miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.

  2011cited by this paper
• Simultaneous siRNA Targeting of Src and Downstream Signaling Molecules Inhibit Tumor Formation and Metastasis of a Human Model Breast Cancer Cell Line

  2011cited by this paper
• Abstract LB-400: STAT3 mediates resistance to MEK inhibitor through microRNA miR-17

  2011cited by this paper
• STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma.

  2011cited by this paper
• CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

  2010cited by this paper
• Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression

  2010cited by this paper
• Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

  2010influential reference
• Prognostic significance and mechanism of Treg infiltration in human brain tumors.

  2010cited by this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cited by this paper
• Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses

  2010cited by this paper
• STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.

  2010cited by this paper
• Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

  2010cited by this paper
• STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells

  2009cited by this paper
• In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses

  2009cited by this paper
• miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

  2008cited by this paper
• Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

  2008cited by this paper
• MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

  2008cited by this paper
• The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing

  2008cited by this paper
• REST maintains self-renewal and pluripotency of embryonic stem cells

  2008cited by this paper
• Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment

  2007cited by this paper
• Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

  2007cited by this paper
• The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development.

  2007cited by this paper
• MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.

  2007cited by this paper
• Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.

  2007cited by this paper
• The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

  2007cited by this paper
• STAT3-mediated anti-inflammatory signalling.

  2006cited by this paper
• Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

  2005cited by this paper
• Shc3 affects human high-grade astrocytomas survival

  2005cited by this paper
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

  2005cited by this paper
• Regulation of miRNA expression during neural cell specification

  2005cited by this paper
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas.

  1985cited by this paper
• Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies.

  1984cited by this paper
• Relationship of lymphocyte invasion and survival of brain tumor patients

  1978cited by this paper
• Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases.

  1978cited by this paper

• Targeting JAK/STAT axis in solid tumors: resolving the therapeutic paradox through upstream suppression and downstream disruption

  2026cites this paper
• Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects.

  2026cites this paper
• Qingda Granules alleviate brain damage in spontaneously hypertensive rats by modulating the miR-124/STAT3 signaling axis.

  2025cites this paper
• The Impact of Senescence-Associated Secretory Phenotype (SASP) on Head and Neck Cancers: From Biology to Therapy

  2025cites this paper
• Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy.

  2025cites this paper
• Novel Small-Molecule miR-124 Inducer Acts as "a Physiological Brake" of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis.

  2025cites this paper
• Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches

  2025cites this paper
• Interplay Between MicroRNAs and Breast Cancer Therapies: Personalized Therapeutic Potential for HER2-Low Breast Cancer

  2025cites this paper
• Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair

  2025cites this paper
• In Silico Identification of circPIM1/miR-16-5p/miR-195-5p/PIM1 Feed-Forward Loop in Recurrent Grade 2 Meningioma

  2025cites this paper
• Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma

  2025cites this paper
• Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study

  2024cites this paper
• MicroRNA-mediated metabolic regulation of immune cells in cancer: an updated review

  2024cites this paper
• The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity

  2024cites this paper
• miRNAs in radiotherapy resistance of cancer; a comprehensive review

  2024cites this paper
• Tumor-specific Polycistronic miRNA Delivered by Engineered Exosomes for the Treatment of Glioblastoma.

  2023cites this paper
• Molecular Mechanisms Involved in the Regulation of Neurodevelopment by miR-124

  2023cites this paper
• Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions.

  2023cites this paper
• Gamma Knife Radiosurgery Modulates micro-RNA Levels in Patients with Brain Metastasis.

  2023cites this paper
• miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma.

  2023cites this paper
• Immune function of colon cancer associated miRNA and target genes

  2023cites this paper
• Noncoding RNAs Controlling Oxidative Stress in Cancer

  2023influential citation
• Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy

  2023cites this paper
• Nucleic acid immunotherapeutics and vaccines: a promising approach to glioblastoma multiforme treatment.

  2023cites this paper
• The Significant Role of microRNAs in Gliomas Angiogenesis: A Particular Focus on Molecular Mechanisms and Opportunities for Clinical Application

  2023cites this paper
• Nucleic acid drug vectors for diagnosis and treatment of brain diseases

  2023cites this paper
• Is There a Role for Immunotherapy in Central Nervous System Cancers?

  2022cites this paper
• HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis

  2022cites this paper
• RNA and RNA Derivatives: Light and Dark Sides in Cancer Immunotherapy

  2022cites this paper
• The Role of NcRNAs to Regulate Immune Checkpoints in Cancer

  2022cites this paper
• ABX464 (Obefazimod) Upregulates miR-124 to Reduce Proinflammatory Markers in Inflammatory Bowel Diseases

  2022cites this paper
• Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system

  2022cites this paper
• Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression

  2022cites this paper
• Non-coding RNAs and glioma: Focus on cancer stem cells

  2022cites this paper
• Oncogenic magnesium transporter 1 upregulates programmed death-1-ligand 1 expression and contributes to growth and radioresistance of glioma cells through the ERK/MAPK signaling pathway

  2022cites this paper
• The Role of Micro RNAs in Regulating PI3K/AKT Signaling Pathways in Glioblastoma

  2022cites this paper
• STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer

  2022cites this paper
• STAT3 Role in T-Cell Memory Formation

  2022cites this paper
• Apoptosis evasion via long non-coding RNAs in colorectal cancer

  2022cites this paper
• Viral Infections and Temporal Programming of Autism Spectrum Disorders in the Mother's Womb

  2022cites this paper
• Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II study

  2022cites this paper
• Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy

  2022cites this paper
• Role of miRNAs in the regulation of cancer-associated signaling pathways

  2022cites this paper
• The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma

  2021cites this paper
• miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors

  2021cites this paper
• Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme

  2021cites this paper
• miRNAs in the Regulation of Cancer Immune Response: Effect of miRNAs on Cancer Immunotherapy

  2021cites this paper
• Leveraging the replication‐competent avian‐like sarcoma virus/tumor virus receptor‐A system for modeling human gliomas

  2021cites this paper
• Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?

  2021cites this paper
• miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases

  2021cites this paper
• Regulation of Adaptive Tumor Immunity by Non-Coding RNAs

  2021cites this paper
• A Comprehensive Analysis of the Downregulation of miRNA-1827 and Its Prognostic Significance by Targeting SPTBN2 and BCL2L1 in Ovarian Cancer

  2021cites this paper
• Glioblastoma cell-induced immunosuppression causing chemoresistance

  2021cites this paper
• Noncoding RNAs involved in the STAT3 pathway in glioma

  2021cites this paper
• Making sense of IL‐6 signalling cues in pathophysiology

  2021cites this paper
• Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment

  2021cites this paper
• Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment

  2021cites this paper
• The immune landscape of common CNS malignancies: implications for immunotherapy

  2021cites this paper
• Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy

  2021cites this paper
• MicroRNAs: immune modulators in cancer immunotherapy

  2021cites this paper
• CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis

  2021cites this paper
• Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development

  2021cites this paper
• Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

  2021cites this paper
• Tumor-Derived Exosomes Enriched by miRNA-124 Promote Anti-tumor Immune Response in CT-26 Tumor-Bearing Mice

  2021cites this paper
• Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression

  2021cites this paper
• Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?

  2021cites this paper
• Review MicroRNAs: immune modulators in cancer immunotherapy

  2021cites this paper
• High Diagnostic and Prognostic Value of miRNAs Compared with the Carcinoembryonic Antigen as a Traditional Tumor Marker.

  2021cites this paper
• MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer

  2021influential citation
• High-throughput fluorescence-based screen identifies the neuronal 1 microRNA miR-124 as a positive regulator of alphavirus infection

  2020cites this paper
• MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme

  2020cites this paper
• MicroRNA-124 regulates cell pyroptosis during cerebral ischemia-reperfusion injury by regulating STAT3

  2020cites this paper
• Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer

  2020cites this paper
• Anti–PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells

  2020cites this paper
• Exosomes in Tumor Immunotherapy: Mediator, Drug Carrier, and Prognostic Biomarker

  2020cites this paper
• Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration

  2020cites this paper
• Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells

  2020cites this paper
• Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy

  2020cites this paper
• Cancer Stem Cells: New Horizons in Cancer Therapies

  2020cites this paper
• Enterovirus A71 Oncolysis of Malignant Gliomas.

  2020cites this paper
• miR-525-5p Modulates Proliferation and Epithelial–Mesenchymal Transition of Glioma by Targeting Stat-1

  2020cites this paper
• Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation

  2020cites this paper
• MiR-188-3p/GPR26 modulation functions as a potential regulator in manipulating glioma cell properties

  2020cites this paper
• OTT_A_257951 9957..9966

  2020cites this paper
• MicroRNA124-IL6R Mediates the Effect of Nicotine in Inflammatory Bowel Disease by Shifting Th1/Th2 Balance Toward Th1

  2020cites this paper
• Cancer Stem Cells as a Seed for Cancer Metastasis

  2020cites this paper
• MicroRNAs in the Tumor Microenvironment.

  2020cites this paper
• Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme

  2020cites this paper
• Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?

  2020cites this paper
• Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis

  2019cites this paper
• Regulatory Network of Two Tumor-Suppressive Noncoding RNAs Interferes with the Growth and Metastasis of Renal Cell Carcinoma

  2019cites this paper
• The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy

  2019cites this paper
• High risk glioblastoma cells revealed by machine learning and single cell signaling profiles

  2019cites this paper
• miR-124 and Parkinson's disease: a biomarker with therapeutic potential.

  2019cites this paper
• Immune biology of glioma associated macrophages and microglia: Functional and therapeutic implications.

  2019cites this paper
• MicroRNA therapeutics in glioblastoma: Candidates and targeting strategies

  2019cites this paper
• STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

  2019influential citation
• MicroRNA based theranostics for brain cancer: basic principles

  2019cites this paper
• Downregulation of microRNA‐124 prevents the development of acute liver failure through the upregulation of PIM‐3

  2019cites this paper
• High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection

  2019cites this paper